ES471981A1 - Un procedimiento para la preparacion de derivados de imida- zoquinazolina - Google Patents

Un procedimiento para la preparacion de derivados de imida- zoquinazolina

Info

Publication number
ES471981A1
ES471981A1 ES471981A ES471981A ES471981A1 ES 471981 A1 ES471981 A1 ES 471981A1 ES 471981 A ES471981 A ES 471981A ES 471981 A ES471981 A ES 471981A ES 471981 A1 ES471981 A1 ES 471981A1
Authority
ES
Spain
Prior art keywords
lower alkyl
preparation
group
pharmaceutical preparations
quinazoline derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES471981A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES471981A1 publication Critical patent/ES471981A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un procedimiento para la preparación de derivados de imidazoquinazolina de la fórmula general **(Fórmula)** en donde R1 y R2 representan, cada uno, un átomo de hidrógeno o de halógeno o un grupo de alquilo inferior, hidroxilo, alcoxilo inferior, hidroxi-(alquilo inferior), (alcoxilo inferior)-(alquilo inferior), fenilo, fenoxilo, amino, alquilamino inferior, o di(alquilo inferior) amino o R1 y R2 en átomos de carbono adyacentes representan, juntos, un grupo metilendioxílico, R3 representa un átomo de hidrógeno o un grupo de alquilo inferior o fenilo y R4 representa un grupo de alquilo inferior, hidroxi-(alquilo inferior), (alcoxilo inferior)-(alquilo inferior), aril-(alquilo inferior) o arilo, sus tautómeros y las sales de éstos compuestos.
ES471981A 1977-07-25 1978-07-24 Un procedimiento para la preparacion de derivados de imida- zoquinazolina Expired ES471981A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU77829 1977-07-25
CH577678 1978-05-26

Publications (1)

Publication Number Publication Date
ES471981A1 true ES471981A1 (es) 1979-10-16

Family

ID=25698353

Family Applications (2)

Application Number Title Priority Date Filing Date
ES471981A Expired ES471981A1 (es) 1977-07-25 1978-07-24 Un procedimiento para la preparacion de derivados de imida- zoquinazolina
ES476955A Expired ES476955A1 (es) 1977-07-25 1979-01-18 Un procedimiento para la preparacion de derivados se imida- zoquinazolina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES476955A Expired ES476955A1 (es) 1977-07-25 1979-01-18 Un procedimiento para la preparacion de derivados se imida- zoquinazolina.

Country Status (29)

Country Link
US (1) US4256748A (es)
EP (1) EP0000718B1 (es)
JP (1) JPS5441894A (es)
AR (1) AR218500A1 (es)
AT (1) AT363479B (es)
AU (1) AU519688B2 (es)
BR (1) BR7804763A (es)
CA (1) CA1094555A (es)
CS (1) CS203014B2 (es)
DE (2) DE2832138A1 (es)
DK (1) DK144128C (es)
ES (2) ES471981A1 (es)
FI (1) FI63409C (es)
FR (1) FR2398748A1 (es)
GB (1) GB2001638B (es)
GR (1) GR72968B (es)
HU (1) HU177643B (es)
IE (1) IE47280B1 (es)
IL (1) IL55183A (es)
IT (1) IT1097337B (es)
MC (1) MC1199A1 (es)
MY (1) MY8500249A (es)
NL (1) NL7807507A (es)
NO (1) NO150800C (es)
NZ (1) NZ187921A (es)
PH (1) PH14642A (es)
PT (1) PT68342A (es)
SE (1) SE7808111L (es)
YU (1) YU177578A (es)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7807507A (nl) 1977-07-25 1979-01-29 Hoffmann La Roche Tricyclische verbindingen.
US4146718A (en) * 1978-04-10 1979-03-27 Bristol-Myers Company Alkyl 5,6-dichloro-3,4-dihydro-2(1h)-iminoquinazoline-3-acetate hydrohalides
CA1131631A (en) * 1979-06-20 1982-09-14 Madhukar S. Chodnekar Quinazoline derivatives and pharmaceutical preparations
EP0029559A3 (en) * 1979-11-24 1981-09-30 Sandoz Ag 5,10-dihydroimidazo(2,1-b)quinazolines, their production and pharmaceutical compositions containing them
US4444768A (en) * 1980-03-04 1984-04-24 Ciba-Geigy Corporation Pyrimido[1,6-a]indoles, pharmaceutical preparations containing them, and methods of treating pain and inflammation with them
ZW16481A1 (en) * 1980-08-15 1982-03-10 Hoffmann La Roche Novel imidazoquinazoline derivatives
EP0054180A3 (de) * 1980-12-16 1982-12-01 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung eines Imidazochinazolinonderivates
JPS57178234U (es) * 1981-05-06 1982-11-11
US4455311A (en) * 1981-08-28 1984-06-19 Hoffmann-La Roche Inc. Imidazoquinazoline derivatives which inhibit the aggregation of blood platelets, inhibit gastric secretion or have activity on the circulatory system
US4551459A (en) * 1983-02-16 1985-11-05 Syntex (U.S.A.) Inc. Method of treating heart failure using (2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-b]quinazolinyl)oxyalkylamides
US4490371A (en) * 1983-02-16 1984-12-25 Syntex (U.S.A.) Inc. N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
US4663320A (en) * 1983-02-16 1987-05-05 Syntex (U.S.A.) Inc. (2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof
JPS604186A (ja) * 1983-06-21 1985-01-10 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン化合物
JPS6028979A (ja) * 1983-07-14 1985-02-14 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン類化合物
ES8607299A1 (es) * 1984-02-15 1986-06-01 Syntex Inc Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimida- zo(2,1-b)quinazolinil)-oxialquilamidas
US4783467A (en) * 1985-06-05 1988-11-08 Pfizer Inc. Tetrahydroimidazoquinazolinone inotropic agents
GB8514207D0 (en) * 1985-06-05 1985-07-10 Pfizer Ltd Cardiac stimulants
US4837239A (en) * 1985-08-23 1989-06-06 Syntex (U.S.A.) Inc. Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
US4670434A (en) * 1985-11-14 1987-06-02 Syntex (U.S.A.) Inc. (2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors
US4775674A (en) * 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) * 1986-07-08 1987-10-20 Bristol-Myers Company 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US5043327A (en) * 1989-07-18 1991-08-27 Janssen Pharmaceutica N.V. Positive inotropic and lusitropic 3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one derivatives, compositions and use
US4943573A (en) * 1989-11-01 1990-07-24 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
CA2113115A1 (en) * 1991-07-29 1993-02-18 Vlad E. Gregor Quinazoline derivatives as acetylcholinesterase inhibitors
US5196428A (en) * 1992-04-03 1993-03-23 Bristol-Myers Squibb Company Imidazo[4,5-b]qinolinyl oxy alkyl ureas
US5158958A (en) * 1992-04-03 1992-10-27 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl sulfonyl piperidine derivatives
US5348960A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl tetrazolyl piperidine derivatives
US5208237A (en) * 1992-04-03 1993-05-04 Bristol-Meyers Squibb Company 7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones
JPH06167328A (ja) * 1992-05-26 1994-06-14 Mayekawa Mfg Co Ltd 氷厚測定装置
EP1216037A2 (en) * 1999-09-21 2002-06-26 Emory University Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents
US6388073B1 (en) * 2000-07-26 2002-05-14 Shire Us Inc. Method for the manufacture of anagrelide
EA200801731A1 (ru) * 2003-01-23 2009-10-30 Шир Холдингз Аг Составы и способы лечения тробмоцитемии
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US20060030574A1 (en) * 2004-08-04 2006-02-09 Shire Holdings Ag Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
US7700608B2 (en) * 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US8426429B2 (en) 2004-08-06 2013-04-23 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8383637B2 (en) 2004-08-06 2013-02-26 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8436006B2 (en) 2004-08-06 2013-05-07 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
US7910597B2 (en) * 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
GB0623750D0 (en) * 2006-11-28 2007-01-10 Shire Llc Substituted quinazolines
MX2009013293A (es) 2007-06-04 2010-02-15 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
GB0808953D0 (en) * 2008-05-16 2008-06-25 Shire Llc substituted quinazolines
GB0808950D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
GB0808951D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
GB0808967D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substitute quinazolines
GB0808968D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substitute quinazolines
GB0808947D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
GB0808944D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
GB0808948D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
GB0808952D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
GB0810005D0 (en) * 2008-06-02 2008-07-09 Shire Llc Substituted quinazolines
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
GB0822970D0 (en) 2008-12-17 2009-01-21 Shire Llc Process for the preparation of anagrelide and analogues
GB201004495D0 (en) 2010-03-18 2010-05-05 Shire Llc Subtituted quinazolines
GB201004491D0 (en) 2010-03-18 2010-05-05 Shire Llc Quinazoline analogues
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA3100941C (en) 2011-03-01 2024-03-05 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
EP3718557A3 (en) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
KR20160042039A (ko) 2013-08-09 2016-04-18 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
JP5935843B2 (ja) * 2014-08-08 2016-06-15 Ｊｆｅスチール株式会社 スポット溶接性に優れた冷延鋼板およびその製造方法
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
EP4201403A1 (en) 2021-12-21 2023-06-28 Som Innovation Biotech, S.L. Compounds tirapazamine and quazinone for use in the treatment of gm2 gangliosidoses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1645917A1 (de) 1962-10-26 1970-09-24 American Home Prod Verfahren zur Herstellung von 5-Aryl-3-acyloxy-1,2-dihydro-3H-1,4-benzodiazepin-2-onen
GB1037375A (en) 1964-08-07 1966-07-27 Hoffmann La Roche A process for the manufacture of benzodiazepine derivatives
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
BE794964A (fr) * 1972-02-04 1973-08-02 Bristol Myers Co Nouveaux agents hypotenseurs et procede pour les preparer
US3983119A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
US3988340A (en) * 1975-01-23 1976-10-26 Bristol-Myers Company 6-Alkoxymethyl-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones and 7-alkoxymethyl-6-[H]-1,2,3,4-tetrahydropyrimido[2,1-b]quinazolin-2-ones
NL7807507A (nl) 1977-07-25 1979-01-29 Hoffmann La Roche Tricyclische verbindingen.

Also Published As

Publication number Publication date
YU177578A (en) 1983-01-21
DK144128B (da) 1981-12-14
JPS5441894A (en) 1979-04-03
FR2398748B1 (es) 1981-09-04
MY8500249A (en) 1985-12-31
PT68342A (en) 1978-08-01
IT1097337B (it) 1985-08-31
MC1199A1 (fr) 1979-03-19
DK328978A (da) 1979-01-26
IT7826019A0 (it) 1978-07-24
DK144128C (da) 1982-05-17
NO150800C (no) 1984-12-27
AR218500A1 (es) 1980-06-13
EP0000718B1 (de) 1982-03-24
BR7804763A (pt) 1979-04-10
AT363479B (de) 1981-08-10
CA1094555A (en) 1981-01-27
ES476955A1 (es) 1979-10-16
FI63409B (fi) 1983-02-28
IE781478L (en) 1979-01-25
EP0000718A2 (de) 1979-02-21
IL55183A (en) 1981-11-30
NZ187921A (en) 1981-03-16
ATA535178A (de) 1981-01-15
GB2001638B (en) 1982-02-10
NO782541L (no) 1979-01-26
GB2001638A (en) 1979-02-07
US4256748A (en) 1981-03-17
FI63409C (fi) 1983-06-10
CS203014B2 (en) 1981-02-27
FR2398748A1 (fr) 1979-02-23
IL55183A0 (en) 1978-09-29
HU177643B (en) 1981-11-28
GR72968B (es) 1984-01-20
NL7807507A (nl) 1979-01-29
PH14642A (en) 1981-10-12
EP0000718A3 (en) 1979-06-13
IE47280B1 (en) 1984-02-08
DE2861688D1 (en) 1982-04-29
NO150800B (no) 1984-09-10
SE7808111L (sv) 1979-01-26
AU3812778A (en) 1980-01-24
FI782248A7 (fi) 1979-01-26
AU519688B2 (en) 1981-12-17
DE2832138A1 (de) 1979-02-08

Similar Documents

Publication Publication Date Title
HUP0004437A2 (hu) Raf kinázt gátló hatású, szimmetrikusan és aszimmetrikusan szubsztituált difenil-karbamid-származékok és ezeket a vegyületeket tartalmazó gyógyászati készítmények
ES2029786T3 (es) Procedimiento para preparar nuevos derivados de quinolina.
ES8308311A1 (es) Procedimiento para la preparacion de derivados de benzazepina.
ES8601146A1 (es) Procedimiento para preparar derivados azolicos
ES8601934A1 (es) Un procedimiento para la preparacion de nuevos derivados de triazina.
SE8206282D0 (sv) Ergolinderivat och forfarande for deras framstellning samt farmaceutiska kompositioner der de ingar
FI873726A0 (fi) Dihydropyridinfoereningar, foerfaranden foer deras framstaellning och deras anvaendning.
GB1369379A (en) Benzodioxole derivatives and processes for preparing them
GB1432809A (en) Coumarin derivatives
ES497064A0 (es) Un procedimiento para la preparacion de indolo benzoxazinas.
DK209176A (da) Fremgangsmade til fremstilling af n-substituerede phenylpiperidinderivater eller salte deraf
DK160184D0 (da) Bis-(piperazinyl-eller homopiperazinyl)-alkaner og syreadditionssalte deraf,fremgangsmaade til deres fremstilling samt deres anvendelse
DK248788A (da) Bicycliske sulfonamidderivater samt fremgangsmaade til fremstilling deraf
ES471239A1 (es) Un metodo para la produccion de compuestos de tiazolidina
DK176085A (da) 4-(nitrophenyl)-tetrahydropyridiner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
FI830152L (fi) Diazolylalkanoler, foerfarande foer deras framstaellning och deras anvaendning saosom antimykotiskamedel
ES8603825A1 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo piperidinopropanolico sustituido y sus sa- les de adicion acidas y amonicas cuaternarias
ES2035849T3 (es) Procedimiento para preparar derivados de eter difenilico.
AR041652A1 (es) Compuestos benzoxazoles u oxazolopiridinas, un procedimiento de preparacion y composiciones farmaceuticas que los contienen
ES8801264A1 (es) Procedimiento para la obtencion de derivados de piridazo(1,2-a)(1,2)diacepina
ES391627A1 (es) Procedimiento para la obtencion de derivados de alcanolami-nas.
ES469450A1 (es) Ÿun procedimiento para la preparacion de bencilpirimidinasŸ
GB1244682A (en) Anti-viral agents
PT87954A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de dioxopiperidina, com efeito antipsicotico
ES554054A0 (es) Procedimiento para preparar piridin-1-oxidos varias veces substituidos

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010201